Meningococcal capsular polysaccharide-protein conjugate (MCV)

Meningococcal capsular polysaccharide-protein conjugates are the active antigenic components of conjugate vaccines used to prevent invasive disease caused by Neisseria meningitidis. These molecules are formed by the covalent attachment of bacterial capsular polysaccharides to immunogenic carrier proteins like CRM197 or tetanus toxoid (CDC, 2023). This conjugation is essential because polysaccharides alone are T-cell independent antigens, which are poorly immunogenic in infants and do not induce long-term memory (WHO, 2021). When the conjugate is administered, the carrier protein allows the immune system to engage T-helper cells through the major histocompatibility complex (MHC) class II pathway (Pollard et al., 2009). This interaction facilitates B-cell maturation, class switching to IgG, and the development of memory B cells, providing durable protection (StatPearls, 2023). The vaccines targeting these conjugates are effective against various serogroups, including A, C, W, and Y, which are major causes of meningitis and septicemia globally. Beyond individual protection, these conjugates help reduce nasopharyngeal carriage of the bacteria, leading to herd immunity within populations. Clinical efficacy is typically monitored through serum bactericidal activity (SBA) assays, which measure the ability of vaccine-induced antibodies to kill the bacteria in the presence of complement.

Other names

Meningococcal conjugate vaccineNeisseria meningitidis capsular polysaccharide-protein conjugateGlycoconjugate vaccineMenACWY-conjugateMenC-conjugate

The conjugation of meningococcal capsular polysaccharides to a carrier protein converts the polysaccharide from a T-cell independent antigen to a T-cell dependent antigen. This process allows the recruitment of T-helper cells, which stimulate B-cells to undergo class switching and affinity maturation, resulting in high-titer IgG antibodies and the establishment of long-term immunological memory (Pollard et al., 2009).